Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis.

AUTOR(ES)

Carratala, J

RESUMO

We studied 122 stool samples collected from 25 patients with hematologic malignancies who received prophylactic norfloxacin. Fecal samples were obtained at admission and twice weekly thereafter during prophylaxis. Fluoroquinolone-resistant Escherichia coli strains were isolated from the feces of 10 (40%) of the patients; two patients had fluoroquinolone-resistant E. coli strains prior to beginning norfloxacin treatment, and in the other eight patients, the strains appeared subsequently. One patient developed fluoroquinolone-resistant E. coli bacteremia after 10 days of norfloxacin administration.

Documentos Relacionados

• Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center.
• Molecular epidemiology of fluoroquinolone-resistant Escherichia coli bloodstream isolates from patients admitted to European cancer centers.
• Characterization of fluoroquinolone-resistant mutants of escherichia coli selected in vitro.
• Lack of emergence of resistant fecal flora during successful prophylaxis of traveler's diarrhea with norfloxacin.
• Purification and properties of DNA gyrase from a fluoroquinolone-resistant strain of Escherichia coli.